Biocon Ltd.

BSE: BIOCON532523ISIN INE376G01013

Healthcare
Pharmaceuticals
BSE 200

Share price

₹344.00+0.65 (+0.19%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹447.00
52W low: ₹318.50
Off 52W high: -23.04%
1M return: -6.96%
3M return: -19.06%
6M return: -9.65%
1Y return: -9.53%
20D avg volume: 1,75,867
50 DMA: ₹372.66
200 DMA: ₹390.26

Key ratios Consolidated

Market cap: ₹56,061 Cr
Current price: ₹344.00
52W high / low: ₹447.00 / ₹318.50
Face value: ₹5.00
P/E: 134.63
P/B: 1.61
EPS (TTM): ₹2.56
Book value / share: ₹213.81
ROE: —
ROCE: 2.90%
Operating margin: —
Net margin: —
Debt / equity: 0.40
Net debt: ₹12,408 Cr
Interest cover: 1.45
Dividend yield: 0.15%
Dividend / share (TTM): ₹0.50
Payout: 19.53%
Cash conversion cycle: 114.3 days

Financials

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	4,389	4,336	4,517	4,173	4,296	3,942	4,417	3,821	3,590	3,433	3,917	3,954
	34.50	54.50	52.50	117.30	93.00	79.70	36.90	34.80	32.50	1,134	48.60	565.50
	4,423	4,390	4,569	4,290	4,388	4,022	4,454	3,856	3,623	4,567	3,966	4,519
	4,362	4,249	4,241	4,065	4,205	3,925	3,988	3,718	3,550	3,454	3,635	3,708
	1,669	1,424	1,359	1,327	1,368	1,224	1,114	1,293	1,009	860.10	1,478	1,402
	311.20	381.90	222.60	167.90	135.00	837.10	83.50	85.50	49.10	408.50	0.10	33.30
	891.90	916.10	912.10	875.10	887.70	833.10	811.10	788.30	789.60	755.40	741.60	720.80
	240.10	213.20	231.50	209.90	272.20	276.70	212.40	223.40	225.60	236.00	227.00	266.70
	563.80	547.40	513.40	515.30	473.00	455.00	436.30	425.40	419.90	405.40	407.00	414.50
	1,145	1,105	1,185	1,125	1,025	954.80	1,055	956.10	977.20	—	1,004	1,076
	61.50	141.10	327.90	225.60	183.20	96.90	466.40	137.80	72.40	1,114	330.50	811.10
	-6.70	-13.50	-80.40	-293.40	-11.90	0.00	20.40	18.10	26.00	32.00	-8.80	21.20
	54.80	127.60	247.50	-67.80	171.30	96.90	486.80	155.90	98.40	1,146	321.70	832.30
	-1.90	-9.20	48.90	-16.00	38.50	7.70	27.40	74.80	71.30	283.70	96.10	54.90
	56.70	136.80	198.60	-51.80	132.80	89.20	459.40	81.10	27.10	861.80	222.90	753.30
	0.25	0.87	0.79	1.08	0.66	0.26	2.88	0.21	-0.13	5.51	1.13	5.52
Key metrics
	858.70	888.20	992.40	657.40	916.50	828.60	1,136	804.70	743.90	1,787	955.70	1,514
	19.60%	20.50%	22.00%	15.80%	21.30%	21.00%	25.70%	21.10%	20.70%	52.10%	24.40%	38.30%
	1.30%	3.20%	4.40%	-1.20%	3.10%	2.30%	10.40%	2.10%	0.80%	25.10%	5.70%	19.10%
	0.60%	—	1.00%	—	1.00%	—	1.60%	—	—	—	—	—
	2.20%	10.00%	2.30%	9.20%	19.60%	14.80%	12.80%	-3.30%	—	—	—	—
	-57.30%	53.40%	-56.80%	-163.90%	390.00%	-89.60%	106.10%	-89.20%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Income statement
	17,414	16,927	15,262	14,756	11,174	8,184	7,106	6,367	5,514	4,130
	258.80	342.50	1,208	865.50	375.90	212.70	254.50	161.40	144.40	206.20
	17,673	17,270	16,470	15,621	11,550	8,397	7,360	6,529	5,659	4,336
	16,917	16,419	14,680	14,000	10,195	7,096	6,226	5,381	4,639	3,747
	5,779	5,278	4,277	5,072	3,191	2,814	2,430	2,168	1,980	1,445
	1,084	1,363	626.60	682.70	626.10	161.10	68.40	85.40	126.80	232.80
	3,595	3,508	3,144	2,664	2,181	1,880	1,741	1,459	1,165	931.10
	894.70	990.30	897.40	974.40	419.00	67.60	57.70	64.90	70.90	61.50
	2,140	1,957	1,687	1,569	1,113	814.20	715.10	552.20	447.80	—
	4,560	4,273	3,754	3,979	3,211	—	—	—	1,329	901.80
	756.10	850.80	1,790	1,621	1,356	1,301	1,134	1,147	1,019	588.70
	-394.00	-402.90	96.50	-11.60	-291.40	-111.10	12.60	67.50	194.60	0.00
	362.10	447.90	1,887	1,609	1,064	1,190	1,147	1,215	1,214	588.70
	21.80	79.10	457.20	227.40	254.10	211.50	221.50	315.10	212.30	156.90
	340.30	368.80	1,429	1,298	643.00	771.60	846.20	870.90	1,003	431.80
	2.99	2.82	8.46	8.55	3.88	5.44	6.32	6.32	15.30	—
Key metrics
	3,397	3,395	4,471	4,153	2,596	2,072	1,920	1,832	1,733	650.20
	19.51%	20.10%	29.30%	28.10%	23.20%	25.30%	27.00%	28.80%	31.40%	15.70%
	1.95%	2.20%	9.40%	8.80%	5.80%	9.40%	11.90%	13.70%	18.20%	10.50%
	—	2.90%	6.30%	—	—	—	—	—	—	—
	5.70%	10.90%	3.40%	32.10%	36.50%	15.20%	11.60%	15.50%	33.50%	—
	-55.37%	-74.20%	10.10%	101.80%	-16.70%	-8.80%	-2.80%	-13.10%	132.20%	—
	—	196.10	1,925	—	—	—	—	—	—	—
	—	5.41	2.84	—	—	—	—	—	—	—
	—	0.40	0.64	—	—	—	—	—	—	—
	—	12,408	14,528	—	—	—	—	—	—	—
	—	114.3	92.5	—	—	—	—	—	—	—
Balance sheet
	—	63,651	58,797	—	—	—	—	—	—	—
	—	17,180	16,286	—	—	—	—	—	—	—
	—	2,416	3,227	—	—	—	—	—	—	—
	—	5,987	5,488	—	—	—	—	—	—	—
	—	6,086	4,931	—	—	—	—	—	—	—
	—	887.10	0.00	—	—	—	—	—	—	—
	—	9,473	8,708	—	—	—	—	—	—	—
	—	6,772	6,549	—	—	—	—	—	—	—
	—	14,069	14,334	—	—	—	—	—	—	—
	—	14,825	17,756	—	—	—	—	—	—	—
	—	4,078	5,350	—	—	—	—	—	—	—
	—	10,746	12,405	—	—	—	—	—	—	—
	—	36,622	27,712	—	—	—	—	—	—	—
Cash flow
	—	1,994	4,061	—	—	—	—	—	—	—
	—	-2,082	-234.10	—	—	—	—	—	—	—
	—	-923.60	-1,854	—	—	—	—	—	—	—
	—	1,798	2,137	—	—	—	—	—	—	—

Metric	Q2 FY27	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24
Income statement
	630.50	624.50	604.70	621.30	583.30	537.10	643.80	562.80	525.40	510.60	532.60	562.80
	90.70	64.80	49.80	74.80	133.80	61.30	62.70	64.20	73.50	41.90	38.90	48.50
	721.20	689.30	654.50	696.10	717.10	598.40	706.50	627.00	598.90	552.50	571.50	611.30
	601.40	619.40	578.30	584.30	631.40	606.00	671.50	630.60	578.00	551.40	549.70	578.40
	299.50	261.90	246.10	287.60	320.70	288.00	322.40	276.80	263.00	223.20	217.70	264.40
	0.00	6.50	0.00	0.00	24.10	21.10	0.00	—	—	—	—	0.20
	117.10	133.10	93.60	121.70	126.20	125.70	124.30	131.90	125.40	119.70	116.80	117.60
	21.90	17.30	16.70	2.30	67.20	56.20	56.70	65.30	59.70	55.20	39.50	56.00
	38.20	38.40	36.20	34.00	33.80	33.30	33.00	33.80	30.50	30.50	29.80	30.90
	143.70	144.00	156.20	154.20	137.80	136.00	141.10	140.20	129.80	—	121.90	125.40
	119.80	69.90	76.20	111.80	85.70	-7.60	35.00	-3.60	20.90	1.10	21.80	32.90
	0.00	0.00	-18.80	-196.30	0.00	0.00	0.00	607.50	—	—	—	—
	119.80	69.90	57.40	-84.50	85.70	-7.60	35.00	603.90	20.90	1.10	21.80	32.90
	28.10	17.70	6.40	-8.10	14.80	0.70	13.80	19.90	17.70	0.20	7.80	8.90
	91.70	52.20	51.00	-76.40	70.90	-8.30	21.20	584.00	3.20	0.90	14.00	24.00
	0.56	0.32	0.32	-0.57	0.55	-0.07	0.18	4.88	0.03	0.01	0.12	0.20
Key metrics
	179.90	125.60	110.30	-48.20	186.70	81.90	124.70	703.00	111.10	86.80	91.10	119.80
	28.50%	20.10%	18.20%	-7.80%	32.00%	15.20%	19.40%	124.90%	21.10%	17.00%	17.10%	21.30%
	14.50%	8.40%	8.40%	-12.30%	12.20%	-1.50%	3.30%	103.80%	0.60%	0.20%	2.60%	4.30%
	0.50%	—	0.30%	—	0.90%	—	0.70%	—	—	—	—	—
	8.10%	16.30%	-6.10%	10.40%	11.00%	5.20%	20.90%	0.00%	—	—	—	—
	29.30%	728.90%	140.60%	-113.10%	2,115.60%	-1,022.20%	51.40%	2,333.30%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18
Income statement
	2,481	2,346	2,243	2,127	1,993	1,738	2,028	1,988	2,885	2,426
	280.10	319.70	242.30	193.00	271.40	187.20	150.20	201.70	117.50	124.70
	2,761	2,666	2,485	2,320	2,264	1,925	2,179	2,190	3,002	2,550
	2,383	2,400	2,432	2,184	2,156	1,786	1,820	1,802	2,649	2,244
	1,095	1,142	1,085	1,033	978.90	912.30	760.70	858.20	1,278	958.70
	6.50	45.20	0.00	0.50	2.10	1.70	0.90	0.90	125.40	92.50
	465.50	467.20	501.30	452.30	433.80	367.70	390.20	344.80	510.30	408.60
	58.20	142.40	236.90	198.80	69.60	0.40	0.40	1.20	2.60	1.00
	146.80	137.30	127.80	121.10	116.90	108.20	103.50	98.00	147.10	136.10
	598.10	584.20	534.70	487.60	554.10	—	—	—	744.10	647.90
	377.70	266.10	53.40	135.80	108.40	139.70	358.80	388.50	353.40	305.80
	-215.10	-215.10	607.50	14.50	2,863	—	—	159.70	198.70	—
	162.60	51.00	660.90	150.30	2,971	139.70	358.80	548.20	552.10	305.80
	44.10	13.80	51.60	31.00	122.80	53.60	78.30	111.90	59.40	67.30
	118.50	37.20	609.30	119.30	2,848	86.10	280.50	440.90	492.70	238.50
	0.63	0.27	5.09	1.00	23.87	0.72	2.36	3.68	8.33	—
Key metrics
	367.60	330.70	1,026	470.20	3,158	248.30	462.70	647.40	701.80	442.90
	14.82%	14.10%	45.70%	22.10%	158.40%	14.30%	22.80%	32.60%	24.30%	18.30%
	4.78%	1.60%	27.20%	5.60%	142.90%	5.00%	13.80%	22.20%	17.10%	9.80%
	—	0.70%	6.50%	—	—	—	—	—	—	—
	6.62%	4.60%	5.40%	6.70%	14.70%	-14.30%	2.00%	-31.10%	18.90%	—
	-82.26%	-93.90%	410.70%	-95.80%	3,208.20%	-69.30%	-36.40%	-10.50%	106.60%	—
	—	-463.10	303.70	—	—	—	—	—	—	—
	—	-4.84	1.02	—	—	—	—	—	—	—
	—	0.04	0.25	—	—	—	—	—	—	—
	—	1,059	2,622	—	—	—	—	—	—	—
	—	200.5	138.6	—	—	—	—	—	—	—
Balance sheet
	—	29,271	15,621	—	—	—	—	—	—	—
	—	2,288	2,170	—	—	—	—	—	—	—
	—	91.40	249.50	—	—	—	—	—	—	—
	—	1,003	829.40	—	—	—	—	—	—	—
	—	875.10	836.30	—	—	—	—	—	—	—
	—	100.60	120.00	—	—	—	—	—	—	—
	—	1,281	1,004	—	—	—	—	—	—	—
	—	588.80	814.40	—	—	—	—	—	—	—
	—	1,965	1,737	—	—	—	—	—	—	—
	—	1,150	2,871	—	—	—	—	—	—	—
	—	1,057	619.50	—	—	—	—	—	—	—
	—	93.50	2,252	—	—	—	—	—	—	—
	—	27,080	11,524	—	—	—	—	—	—	—
Cash flow
	—	-180.10	621.10	—	—	—	—	—	—	—
	—	-6,582	-989.00	—	—	—	—	—	—	—
	—	6,602	494.80	—	—	—	—	—	—	—
	—	283.00	317.40	—	—	—	—	—	—	—

Compounded growth

Standalone

Sales CAGR 3Y: +5.59%
Sales CAGR 5Y: +2.96%
Profit CAGR 3Y: -76.45%
Profit CAGR 5Y: -33.24%
Sales YoY (TTM): +6.62%
Profit YoY (TTM): -82.26%

Consolidated

Sales CAGR 3Y: +14.85%
Sales CAGR 5Y: +18.96%
Profit CAGR 3Y: -16.91%
Profit CAGR 5Y: -15.30%
Sales YoY (TTM): +5.70%
Profit YoY (TTM): -55.37%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 44.68%

Quarter	September 2026	June 2026
Promoter %	44.68%	44.68%

Holder	Type	Holding	Previous	Change
KIRAN MAZUMDAR-SHAW	Promoter	29.73%	29.73%	0.00%
GLENTEC INTERNATIONAL	Promoter	14.56%	14.56%	0.00%
SBI ESG EXCLUSIONARY STRATEGY FUND	Public	9.18%	—	—
ICICI PRUDENTIAL RETIREMENT FUND-PURE EQUITY PLAN	Public	4.07%	—	—
SERUM INSTITUTE LIFE SCIENCES PRIVATE LIMITED	Public	3.40%	3.40%	0.00%
LICI NEW PENSION PLUS GROWTH FUND	Public	2.62%	—	—
KOTAK LARGE & MIDCAP FUND	Public	2.57%	—	—
HDFC MUTUAL FUND - HDFC DIVIDEND YIELD FUND	Public	1.07%	—	—
RAVI RASENDRA MAZUMDAR	Promoter Group	0.33%	0.33%	0.00%
DEV MAZUMDAR	Promoter Group	0.06%	0.06%	0.00%
Mazumdar Shaw Medical Foundation	Promoter Group	0.00%	0.00%	0.00%
Jeeves	Promoter Group	0.00%	0.00%	0.00%
BENEFICIAL HOLDINGS UNDER MGT-4	Public	0.00%	0.00%	0.00%
Glenloch Properties LLP	Promoter Group	0.00%	0.00%	0.00%
Carica Investments	Promoter Group	0.00%	—	—

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%

Filings & corporate actions

Recent announcements

Audio and Video Recording of Q2 FY27 Earnings Call4 Nov 2026 · Company Update / Analyst / Investor Meet
Communication regarding withholding of final dividend for the FY 2025-264 Nov 2026 · Company Update / General
Investor Presentation4 Nov 2026 · Company Update / Investor Presentation
Change in Senior Management Personnel4 Nov 2026 · Company Update / Change in Management
Press Release4 Nov 2026 · Company Update / Press Release / Media Release
Outcome of Board Meeting4 Nov 2026 · Board Meeting / Outcome of Board Meeting
Financial Results for the quarter and half year ended September 30,2026.4 Nov 2026 · Result / Financial Results
Press Release29 Oct 2026 · Company Update / Press Release / Media Release
Earnings Conference Call for Analysts and Investors26 Oct 2026 · Company Update / Analyst / Investor Meet
Biocon Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve To approve and take on record the un-audited ....26 Oct 2026 · Board Meeting / Board Meeting
Company Statement26 Oct 2026 · Company Update / General
Company Statement14 Oct 2026 · Company Update / General
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201812 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Disclosure pursuant to Regulation 30 of SEBI Listing Regulations10 Oct 2026 · Company Update / General
Grant of Employee Stock Options1 Oct 2026 · Company Update / General
Intimation regarding closure of Trading Window30 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Company Secretary25 Sep 2026 · Company Update / General
Press Release21 Sep 2026 · Company Update / Press Release / Media Release
Communication regarding remittance of final dividend for the FY 2025-269 Sep 2026 · Company Update / General
Intimation of Schedule of Meetings with Analyst(s)/Institutional Investor(s)8 Sep 2026 · Company Update / Analyst / Investor Meet
Press Release8 Sep 2026 · Company Update / Press Release / Media Release
Intimation of Schedule of Meetings with Analyst(s)/Institutional Investor(s)31 Aug 2026 · Company Update / Analyst / Investor Meet
Communication regarding remittance of final dividend for the FY 2025-2628 Aug 2026 · Company Update / General
The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mylan Inc.26 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Company Statement25 Aug 2026 · Company Update / General
Company Statement18 Aug 2026 · Company Update / General
Investor Meet11 Aug 2026 · Company Update / Analyst / Investor Meet
Earning call Transcript for Q1 FY2711 Aug 2026 · Company Update / Earnings Call Transcript
Voting Results and Scrutinizer''s report8 Aug 2026 · AGM/EGM / AGM
Investor Meet7 Aug 2026 · Company Update / Analyst / Investor Meet
Newspaper Advertisement7 Aug 2026 · Company Update / Newspaper Publication
Resignation of Statutory auditors of material subsidiaries of the Company.6 Aug 2026 · Company Update / Resignation of Statutory Auditors
Change in Directorate6 Aug 2026 · Company Update / Change in Directorate
Completion of tenure of Statutory Auditors6 Aug 2026 · Company Update / General
Appointment of Statutory Auditors6 Aug 2026 · Company Update / Appointment of Statutory Auditor/s
Change in Directorate6 Aug 2026 · Company Update / Change in Directorate
Proceedings of the 48th AGM of the Company and the Chairperson''s speech.6 Aug 2026 · AGM/EGM / AGM
Audio and video recording of Q1 20276 Aug 2026 · Company Update / Analyst / Investor Meet
Investor Presentation6 Aug 2026 · Company Update / Investor Presentation
Monitoring Agency Report5 Aug 2026 · Company Update / Monitoring Agency Report

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 0.5000	3 Jul 2026	3 Jul 2026	—
Final Dividend - Rs. - 0.5000	4 Jul 2025	4 Jul 2025	—
Final Dividend - Rs. - 0.5000	5 Jul 2024	5 Jul 2024	—

Board meetings

4 Nov 2026 Board Meeting - Financial Results
5 Aug 2026 Board Meeting - Financial Results